Security tooling is not written in a single language. Python powers most automation. C sits at the exploit layer. PowerShell ...

An agentic coding tool tasked with cloning and setting up a seemingly benign GitHub repository could execute a malicious ...

Mortal Shell 2 has launched its Steam public playtest. The sequel ditches the stamina bar for faster, aggressive combat. Early player reception is Very Positive with a 92% approval. Mortal Shell 2 ...

The next step in the youth quest is a technology called chemical reprogramming. The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...

Does prostate cancer screening save lives? The Cochrane, an influential group renowned for its gold-standard medical reviews, has previously addressed that question twice, and twice the answer was ‘no ...

Shell's CEO used a specific phrase on the earnings call that captures how serious the global oil supply situation has become. The shortage Sawan described has an unusual characteristic that means it ...

The oil giant’s earnings in the first three months of the year were more than double the previous quarter’s and follow similarly strong results of European rivals. By Gregory Schmidt and Rebecca F.

[2026-04-11 20:21:11] Service detection performed. Please report any incorrect results at https://nmap.org/submit/ . [2026-04-11 20:21:11] Nmap done: 1 IP address (1 ...

This is read by an automated voice. Please report any issues or inconsistencies here. See more from the L.A. Times in Google Search. Set us as preferred Paramount President Jeff Shell stepped down ...

Mr. Shell, the former chief executive of NBCUniversal, is leaving after becoming entangled in a legal battle with a professional gambler, R.J. Cipriani. By Benjamin Mullin and Lauren Hirsch Jeff Shell ...

Your developers are already running OpenClaw at home. Censys tracked the open-source AI agent from roughly 1,000 instances to over 21,000 publicly exposed deployments in under a week. Bitdefender’s ...

In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers. When Elon Musk was at Davos last week, an interviewer asked him if he thought aging ...